Stay updated on ALX-009 Dose Escalation in Bronchiectasis Clinical Trial
Sign up to get notified when there's something new on the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page.

Latest updates to the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page
- Check6 days agoChange DetectedThe study's conditions section no longer lists Cystic Fibrosis, and the related topics/MedlinePlus Genetics references have been removed, altering the contextual information and available educational links for readers.SummaryDifference0.2%

- Check13 days agoChange DetectedThe page now includes 'Cystic fibrosis' as a related topic and adds MedlinePlus Genetics to the related topics. This expands the background resources available for users reviewing the study record.SummaryDifference0.2%

- Check20 days agoChange DetectedAdded a 2014 U.S. NIH grant/contract note to the study identifiers and updated the page revision to v3.6.6 (replacing the previous v3.6.5).SummaryDifference0.1%

- Check27 days agoChange DetectedThe page no longer shows the 'Cystic Fibrosis' condition and the 'MedlinePlus related topics' section, altering how the study's target conditions and related educational resources are presented.SummaryDifference0.2%

- Check34 days agoChange DetectedAdded Cystic fibrosis to the related topics and introduced a MedlinePlus Genetics link in the related topics section. This provides quick access to genetics resources related to CF on the study page.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a new version of the page content.SummaryDifference0.1%

Stay in the know with updates to ALX-009 Dose Escalation in Bronchiectasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page.